Evaluating bleeding severity in children with newly diagnosed immune thrombocytopenia: a pilot study
Related Experiment Videos
1Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Auenbruggerplatz 30, Graz, Austria. jasmin.pansy@medunigraz.at
Insights
Bleeding signs in childhood immune thrombocytopenia (ITP) improve rapidly within a week. Serial bleeding assessments help monitor individual risk, guiding treatment decisions for children with ITP.
Area of Science:
- Pediatrics
- Hematology
- Immunology
Background:
- Childhood immune thrombocytopenia (ITP) is a bleeding disorder causing low platelet counts.
- Accurate assessment of individual bleeding risk is crucial for guiding ITP treatment decisions.
Purpose of the Study:
- To prospectively evaluate platelet counts and bleeding signs in newly diagnosed childhood ITP.
- To assess the utility of serial bleeding score grading in monitoring ITP patients.
Main Methods:
- A pilot study involving 30 newly diagnosed ITP patients.
- Evaluation of platelet counts and Buchanan bleeding scores at diagnosis, day 2-3, and day 5-8.
- Comparison between treated (n=15) and untreated patients.
Main Results:
- Median platelet counts increased and bleeding scores decreased significantly within one week in both treated and untreated groups.
- Inverse correlation observed between bleeding scores and platelet counts.
- Bleeding signs showed rapid improvement in children with ITP.
Conclusions:
- Bleeding severity in childhood ITP improves quickly within the first week post-diagnosis.
- Serial bleeding score assessment appears valuable for monitoring individual bleeding risk in ITP.
- Further validation in larger cohorts is recommended for serial bleeding grading in ITP management.
Background:
Childhood immune thrombocytopenia (ITP) is a bleeding disorder characterized by decreased platelet counts. Assessment of the individual bleeding risk during the course of the disease would allow more accurately guiding treatment-related decisions in these patients.
Patients And Methods:
We conducted a pilot study and prospectively evaluated platelet counts and bleeding signs using an established bleeding (Buchanan) score in 30 patients with newly diagnosed ITP at 3 different time points (at diagnosis [TP1], on day 2-3 [TP2], and on day 5-8 [TP3]) during the first week after diagnosis. 15 patients received immune modulatory therapy.
Results:
Median platelet counts at the 3 different time points were 13, 19, 32×10 (9)/L (untreated patients) and 2, 7, 37×10 (9)/L (treated patients). Corresponding median cumulative bleeding scores were 5, 2, 0 (untreated patients) and 7, 6, 2 (treated patients). Cumulative median bleeding scores and platelet counts were inversely correlated in treated and untreated patients at all 3 time points. Cumulative median bleeding scores significantly decreased in both groups.
Conclusions:
Bleeding signs in children with newly diagnosed ITP rapidly improve within one week after diagnosis. Serial grading of bleeding severity seems to be useful to comprehensively assess and monitor the individual bleeding risk in these patients, but has to be evaluated and validated in a larger cohort.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:30Venous Thrombosis IV: Nursing Management
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.